![Andre J. Gudger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andre J. Gudger
Direttore/Membro del Consiglio presso
CytoDel LLC
Profilo
Andre J.
Gudger is currently the Director at CytoDel LLC.
Previously, he was the Chairman & Chief Executive Officer at Solvern Innovations, Inc. from 2003 to 2009.
He obtained an undergraduate degree from the University of Maryland and an MBA from The University of North Carolina at Charlotte.
Posizioni attive di Andre J. Gudger
| Società | Posizione | Inizio |
|---|---|---|
CytoDel LLC
 CytoDel LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company which produces recombinant derivatives of botulinum neurotoxin | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Andre J. Gudger
| Società | Posizione | Fine |
|---|---|---|
Solvern Innovations, Inc.
 Solvern Innovations, Inc. Information Technology ServicesTechnology Services Provides information technology development and consultation services | Presidente | 01/01/2009 |
Formazione di Andre J. Gudger
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
9
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solvern Innovations, Inc.
Solvern Innovations, Inc. Information Technology ServicesTechnology Services Provides information technology development and consultation services | Technology Services |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytoDel LLC
CytoDel LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company which produces recombinant derivatives of botulinum neurotoxin | Health Technology |
